(Q40689803)

22 September 2017

title

The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands (English)

1 reference

chronic obstructive pulmonary disease

22 September 2017

0 references

1 reference

Feenstra TL

1

1 reference

22 September 2017

van Genugten ML

2

1 reference

22 September 2017

Hoogenveen RT

3

1 reference

22 September 2017

Wouters EF

4

1 reference

22 September 2017

Rutten-van Mölken MP

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

22 September 2017

published in

1 reference

22 September 2017

volume

164

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

590-596

1 reference

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

The health care costs of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Chronic Illness in the Community and the Concept of ‘Social Prevalence’

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

Worldwide epidemiology of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2003167

10.1164/AJRCCM.164.4.2003167

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference